These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24752198)

  • 1. Matrix metalloproteinases and gut toxicity following cytotoxic cancer therapy.
    Al-Dasooqi N
    Curr Opin Support Palliat Care; 2014 Jun; 8(2):164-9. PubMed ID: 24752198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?
    Al-Dasooqi N; Gibson RJ; Bowen JM; Keefe DM
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):1-9. PubMed ID: 19305997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.
    Al-Dasooqi N; Gibson RJ; Bowen JM; Logan RM; Stringer AM; Keefe DM
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1244-56. PubMed ID: 20682600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment.
    Stringer AM; Gibson RJ; Bowen JM; Logan RM; Yeoh AS; Keefe DM
    J Support Oncol; 2007 Jun; 5(6):259-67. PubMed ID: 17624050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regimen-related gastrointestinal toxicities in cancer patients.
    Sonis ST
    Curr Opin Support Palliat Care; 2010 Mar; 4(1):26-30. PubMed ID: 20040879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.
    Logan RM; Stringer AM; Bowen JM; Yeoh AS; Gibson RJ; Sonis ST; Keefe DM
    Cancer Treat Rev; 2007 Aug; 33(5):448-60. PubMed ID: 17507164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced mucosal barrier dysfunction: an updated review on the role of intestinal tight junctions.
    Wardill HR; Bowen JM
    Curr Opin Support Palliat Care; 2013 Jun; 7(2):155-61. PubMed ID: 23492816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptides 1 and 2: intestinal hormones implicated in the pathophysiology of mucositis.
    Kissow H
    Curr Opin Support Palliat Care; 2015 Jun; 9(2):196-202. PubMed ID: 25872118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.
    Cario E
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):157-64. PubMed ID: 26986508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic strategies for combatting gastrointestinal toxicity.
    Sylvester CL; Anderson PH; Stringer AM
    Curr Opin Support Palliat Care; 2020 Jun; 14(2):142-152. PubMed ID: 32332213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New pharmacotherapy options for chemotherapy-induced alimentary mucositis.
    Wardill HR; Bowen JM; Gibson RJ
    Expert Opin Biol Ther; 2014 Mar; 14(3):347-54. PubMed ID: 24387716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors.
    Thorpe DW; Stringer AM; Gibson RJ
    Exp Biol Med (Maywood); 2013 Jan; 238(1):1-6. PubMed ID: 23479757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases: do they play a role in mucosal pathology of the oral cavity?
    Al-Azri AR; Gibson RJ; Keefe DM; Logan RM
    Oral Dis; 2013 May; 19(4):347-59. PubMed ID: 23033841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal mucositis: the role of MMP-tight junction interactions in tissue injury.
    Al-Dasooqi N; Wardill HR; Gibson RJ
    Pathol Oncol Res; 2014 Jul; 20(3):485-91. PubMed ID: 24424533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced mucositis: the role of mucin secretion and regulation, and the enteric nervous system.
    Thorpe D; Stringer A; Butler R
    Neurotoxicology; 2013 Sep; 38():101-5. PubMed ID: 23827812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases.
    Stringer AM; Al-Dasooqi N; Bowen JM; Tan TH; Radzuan M; Logan RM; Mayo B; Keefe DM; Gibson RJ
    Support Care Cancer; 2013 Jul; 21(7):1843-52. PubMed ID: 23397098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix remodelling: the role of matrix metalloproteinases.
    Stamenkovic I
    J Pathol; 2003 Jul; 200(4):448-64. PubMed ID: 12845612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal mucositis: mechanisms and management.
    Keefe DM
    Curr Opin Oncol; 2007 Jul; 19(4):323-7. PubMed ID: 17545794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of matrix metalloproteinases in inflammatory bowel disease.
    Naito Y; Yoshikawa T
    Mol Aspects Med; 2005; 26(4-5):379-90. PubMed ID: 16112187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.